Abstract
Salbutamol and theophylline are administered in combination orally to provide the sinergistic effect of drugs. The aim of this study is to develop and to validate ion pair liquid chromatography to determine both drugs in pharmaceutical dosage form, especialy in syrup dosage form. Separation of drugs was performed with Spherisorb C-18 column (250 x 4.6 mm; 10 um). The mobile phase used is the mixture of acetic acid 1% : methanol (60 : 40 v/v) which contain 3.5 mM sodium-1-octanesulphonate, as ion pairing reagent. The mobile phase was delivered isocratically with flow rate of 1 mL/min. UV detection was set at wavelength of 277 nm. The developed method was validated in terms of linearity, precision, accuracy, selectivity, and sensitivity. The precision of the method was evaluated using repeatability assay having relative standard deviation (RSD) values of 0.41–0.70 % for theophylline and 0.08 – 0.24 % for salbutamol. The recovery percentages are in the range of 98.28–101.02% (theophylline) and 100.71–101.60% for salbutamol. The developed method meets the validation requirement for analysis of salbutamol and theophylline simultaneously in syrup dosage form. Furthermore, the method also provides acceptable result for syrup and tablet dosage forms containing Salbutamol and theophylline only, and tablet containing the combination of Salbutamol and theophylline. Keywords: teophyllin, salbutamol, HPLC, sodium-1-octanesulphonate, validation.
Highlights
The combination of theophylline, 1, 3dimethyl-7H-purine-2, 6-dione known as dimethylxanthine as long-acting bronchodilator with Salbutamol, 4-[2-(tert-butylamino)-1hydroxyethyl] - 2- phenol, as short acting β-agonist is drug of choice for treatment of chronic obstructive pulmonary disease
ABSTRAC T Salbutamol and theophylline are administered in combination orally to provide the sinergistic effect of drugs
The aim of this study is to develop and to validate ion pair liquid chromatography to determine both drugs in pharmaceutical dosage form, especialy in syrup
Summary
ABSTRAC T Salbutamol and theophylline are administered in combination orally to provide the sinergistic effect of drugs. The aim of this study is to develop and to validate ion pair liquid chromatography to determine both drugs in pharmaceutical dosage form, especialy in syrup. The mobile phase used was the mixture of acetic acid 1% : methanol (60:40v/v) which contain 3.5mM sodium-1octanesulphonate, as ion pairing reagent. The developed method was validated in terms of linearity, precision, accuracy, selectivity, and sensitivity. The developed method met the validation requirement for analysis of salbutamol and theophylline simultaneously in syrup dosage form. The method provided acceptable result for syrup and tablet dosage forms containing Salbutamol and theophylline only, and tablet containing the combination of Salbutamol and theophylline
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.